NAV
₹10.0770
as on 22 Aug 2019 09:10 PM
₹0.0220(0.22%)
Last Change
Schemes Managed By
Investment Performance
would have given a returns of
₹103,499
₹106,749
₹92,058
₹93,345
Bank Account
Fixed Deposit
Regular Mutual Fund
This Fund on Paytm Money
This Mutual Fund
₹6,655
Profit (absolute return)
6.66%
in the last
1m
3m
1y
max
+1% Higher Returns
With Direct Plans on Paytm MoneyInvestment Returns
In the last 3 months
1.15%
In the last 6 months
1.71%
In the last 1 year
6.66%
In the last 3 years
NA
In the last 5 years
NA
In the last 10 years
NA
Absolute Returns
CAGR
Scheme Riskometer
low
moderately low
moderate
moderately high
high
Investors understand that their principal will be at high risk
Scheme Information
Mirae Asset Healthcare Fund Direct - Dividend Payout
as of 22 Aug 2019 09:10 PM
₹334.23 Cr
Scheme Asset Size
Fund Type
Open-End
Exit Load
Exit load of 1% if redeemed within 1 year.
0.76%
Expense Ratio
Plan
Dividend
Benchmark
S&P BSE Healthcare Total Return Index
Exit Load
Exit load of 1% if redeemed within 1 year.
Scheme Document
Sectors Holding in this Mutual Fund
as on 31 Jul 2019
Healthcare
88.54%
₹295.94 Cr
Chemicals
8.46%
₹28.29 Cr
Financial
1.91%
₹6.38 Cr
Cash Holding
1.04%
₹3.48 Cr
Companies Holding in this Mutual Fund
as on 31 Jul 2019
Sun Pharmaceutical Inds. Ltd.
13.38%
₹44.72 Cr
Divi's Laboratories Ltd.
10.44%
₹34.89 Cr
Cipla Ltd.
8.68%
₹29.01 Cr
Dr. Reddy's Laboratories Ltd.
7.78%
₹26.00 Cr
Torrent Pharmaceuticals Ltd.
7.24%
₹24.20 Cr
Aurobindo Pharma Ltd.
5.26%
₹17.58 Cr
Ipca Laboratories Ltd.
4.96%
₹16.58 Cr
Lupin Ltd.
4.55%
₹15.21 Cr
Dr. Lal Pathlabs Ltd.
4.25%
₹14.20 Cr
Vinati Organics Ltd.
4.11%
₹13.74 Cr
View All
View All
Companies Holding in this Mutual Fund
as on 31 Jul 2019
Sun Pharmaceutical Inds. Ltd.
13.38%
₹44.72 Cr
Divi's Laboratories Ltd.
10.44%
₹34.89 Cr
Cipla Ltd.
8.68%
₹29.01 Cr
Dr. Reddy's Laboratories Ltd.
7.78%
₹26.00 Cr
Torrent Pharmaceuticals Ltd.
7.24%
₹24.20 Cr
Aurobindo Pharma Ltd.
5.26%
₹17.58 Cr
Ipca Laboratories Ltd.
4.96%
₹16.58 Cr
Lupin Ltd.
4.55%
₹15.21 Cr
Dr. Lal Pathlabs Ltd.
4.25%
₹14.20 Cr
Vinati Organics Ltd.
4.11%
₹13.74 Cr
View All
View All
This fund's returns:
6.66%Return Duration
1 Year
Mirae Asset Healthcare Fund Direct - Growth
EquityPharma
Min. Investment
₹1000
Category Returns
-15.51%
-6.65%
1Y Returns
-6.65
Tata India Pharma & HealthCare Fund Direct-Growth
EquityPharma
Min. Investment
₹500
Category Returns
-15.51%
-6.65%
1Y Returns
-6.76
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Direct - Growth
EquityPharma
Min. Investment
₹100
Category Returns
-15.51%
-6.65%
1Y Returns
-10.09
Reliance Pharma Fund Direct-Growth
EquityPharma
Min. Investment
₹100
Category Returns
-15.51%
-6.65%
1Y Returns
-10.16
UTI Healthcare Fund Direct-Growth
EquityPharma
Min. Investment
₹500
Category Returns
-15.51%
-6.65%
1Y Returns
-14.04
About Mirae Asset Healthcare Fund Direct - Dividend Payout
Mirae Asset Healthcare Fund Direct - Dividend Payout is a Equity mutual fund scheme from Mirae Asset Mutual Fund. This scheme was launched on 02 Jul 2018 and is currently managed by its fund manager Vrijesh Kasera. It has an AUM of ₹334.23 Crores and the latest NAV decalared is ₹10.077 as on 22 Aug 2019 at 9:10 pm.
Mirae Asset Healthcare Fund Direct - Dividend Payout scheme return performance in last 1 year is -6.65%, is 0.17% since scheme launch. The min. SIP amount to invest in this scheme is ₹1000.
Scheme Objective
The scheme seeks to generate long term capital appreciation through investing in equity and equity related securities of companies benefitting directly or indirectly in Healthcare and allied sectors in India.
Scheme Details
| AUM: | ₹334.23 Cr |
| Category: | Equity: Sectoral-Pharma |
| Launch Date: | 02 Jul 2018 |
| Fund Type: | Open-End |
AMC Information
Mirae Asset Mutual Fund
View AMC Details
₹32,764.54 Cr
AUM
41
Schemes
Address
Unit No.606, 6th Floor,Windsor Building, Off. CST Road,Kalina, Santacruz (East),400098
Phone Number
Phone : 022- 67800301 / 1800 2090 777
Email / Website